Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.

Authors: Stevens, Richard C; Suzuki, Stephanie M; Cole, Toby B; Park, Sarah S; Richter, Rebecca J; Furlong, Clement E

Published In Proc Natl Acad Sci U S A, (2008 Sep 2)

Abstract: The high-density lipoprotein-associated enzyme paraoxonase 1 (PON1) hydrolyzes lactones, aromatic esters, and neurotoxic organophosphorus (OP) compounds, including insecticide metabolites and nerve agents. Experiments with mice lacking PON1 (PON1(-/-) mice) have established that plasma PON1 protects against chlorpyrifos/chlorpyrifos-oxon and diazinon/diazoxon (DZO) exposure but does not protect against parathion/paraoxon or nerve agents. The catalytic efficiency of PON1 determines whether or not it will protect against a given OP exposure. Expression of active recombinant human PON1 (rHuPON1) in Escherichia coli provides a system in which PON1 can be engineered to achieve a catalytic efficiency sufficient to protect against or treat specific OP exposures. Here, we describe the generation of highly purified engineered rHuPON1(K192) that protects against DZO exposure when injected into PON1(-/-) mice. The injected rHuPON1 is nontoxic, persists in serum for at least 2 days after injection, and provides protection against DZO exposures of at least three times the median lethal dose value.

PubMed ID: 18711144 Exiting the NIEHS site

MeSH Terms: Animals; Aryldialkylphosphatase/blood; Aryldialkylphosphatase/isolation & purification*; Aryldialkylphosphatase/metabolism; Aryldialkylphosphatase/pharmacology*; Electrophoresis, Polyacrylamide Gel; Escherichia coli/metabolism*; Humans; Hydrolysis; Injections, Intraperitoneal; Kinetics; Mice; Phosphoric Acid Esters/poisoning*; Protein Engineering*; Recombinant Proteins/administration & dosage; Recombinant Proteins/isolation & purification*; Recombinant Proteins/metabolism; Recombinant Proteins/pharmacology*; Staphylococcal Protein A/metabolism

to Top